famotidine, calcium carbonate, magnesium hydroxide chewable tablet
PEPCID COMPLETE (famotidine, calcium carbonate, magnesium hydroxide chewable tablet) by Kenvue Brands is histamine h2 receptor antagonists [moa]. First approved in 2000.
Drug data last refreshed 2h ago · AI intelligence enriched 1mo ago
PEPCID COMPLETE is a combination chewable tablet containing famotidine (H2 receptor antagonist), calcium carbonate, and magnesium hydroxide for relief of heartburn, acid indigestion, and sour stomach. It works by reducing stomach acid production while providing immediate antacid relief through dual mechanisms. This over-the-counter product targets consumers seeking rapid symptom relief without prescription.
As an OTC product approaching loss of exclusivity, brand team focus shifts from growth initiatives to margin protection and portfolio optimization strategies.
Histamine H2 Receptor Antagonists
Histamine-2 Receptor Antagonist
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on PEPCID COMPLETE offers exposure to OTC portfolio management, competitive positioning strategy, and brand lifecycle optimization in the mature antacid market. This role emphasizes commercial acumen, margin defense, and strategic planning as the product transitions through LOE, making it ideal for professionals developing expertise in portfolio transitions and generic defense strategies.
Worked on PEPCID COMPLETE at Kenvue Brands? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo